Systematic Literature Reviews and AI: A Gold Standard Meets Innovation
3 min read
Discover how Systematic Literature Reviews (SLRs) provide a gold-standard method for evidence synthesis in biomedicine—and how AI is transforming the process. Learn the key steps, differences from other review types, and the future potential of automation in research.

When it comes to making evidence-based decisions in research, policy, or practice, not all literature reviews are created equal.

A Systematic Literature Review (SLR) is widely regarded as the gold standard for synthesizing research evidence. Unlike traditional or narrative reviews, SLRs follow a structured, transparent, and replicable methodology to identify, evaluate, and summarize all relevant studies addressing a specific research question.

The goal? To deliver a comprehensive and unbiased synthesis of the existing literature—produced with methodological rigor and full transparency. While SLRs offer reliable insights that can inform high-stakes decisions, they are also time-consuming and resource-intensive, often requiring close collaboration with domain experts to ensure scientific integrity.


What Sets Systematic Literature Reviews Apart?

SLRs are built on three core principles that distinguish them from other types of literature reviews:

1. A Specific Research Question
Every SLR begins with a clearly defined and focused question that guides the entire review process. This helps narrow the scope and ensures the review addresses a meaningful and answerable problem.

2. Predefined Criteria and Protocols
Before the search begins, detailed protocols are established—covering databases to be searched, keywords, and explicit inclusion and exclusion criteria. These predefined elements help reduce bias and improve consistency.

3. Transparency, Rigor, and Reproducibility
Every step—from study selection to data synthesis—is meticulously documented. This level of detail allows others to critically assess the review or replicate it, strengthening its scientific value.


The SLR Process: Step by Step

SLRs follow a systematic sequence to ensure accuracy and reproducibility:

  • 1. Define the Research Question
    Often framed using models like PICO (Population, Intervention, Comparator, Outcome), this foundational step shapes the entire review.
  • 2. Develop the Search Strategy
    Researchers decide which databases to search, what keywords to use, and which studies to include or exclude—all outlined in advance.
  • 3. Conduct the Search
    A comprehensive literature search is carried out across selected databases. Studies are screened for relevance in two stages: title/abstract review and full-text assessment.
  • 4. Extract the Data
    Standardized extraction forms are used to collect key data—such as study design, sample size, interventions, and outcomes—ensuring consistency across studies.
  • 5. Assess Study Quality
    Each included study is evaluated for methodological rigor and potential bias. For example, the Cochrane Risk of Bias tool is often used for randomized controlled trials.
  • 6. Synthesize the Evidence
    The extracted data is synthesized qualitatively or quantitatively. When appropriate, a meta-analysis combines statistical results across studies.
  • 7. Report the Findings
    Results are presented in a comprehensive report, often accompanied by a PRISMA diagram—a visual summary of how studies were identified, screened, and selected.

Beyond SLR: Other Types of Reviews

Not every question requires a full systematic review. Alternative approaches include:

  • Scoping Reviews
    Ideal for mapping broad areas of research and identifying knowledge gaps.
  • Rapid Reviews
    Streamlined versions of SLRs used in time-sensitive situations where decisions must be made quickly.
  • Narrative Reviews
    More descriptive and interpretive in nature, offering expert commentary but with less methodological structure.

Enter AI: Can Machines Help with SLRs?

Given the complexity and resource demands of conducting high-quality SLRs, it's no surprise that artificial intelligence is emerging as a potential ally.

From automating literature screening and data extraction to summarizing findings, AI tools are being developed to support—and in some cases, accelerate—each stage of the SLR workflow. Even regulatory agencies like the FDA are exploring AI to enhance internal review processes.

But this growing role of AI raises important questions:

  • Do you use any AI tools in your own SLR workflow?
  • Have they improved your efficiency or accuracy?
  • Will AI ever be able to fully automate the systematic review process—and if so, when? If not, what are the barriers?

We’d love to hear your perspective. What role do you think AI should play in the future of systematic reviews?

Other Posts You Might Like
No Perfect Timing: Embracing Uncertainty in Business and Life
Apr 16, 2025
"Is now the right time?" It’s a question I hear often—from aspiring entrepreneurs, working parents, and close friends. Whether it’s starting...
Read more
Calling for Lupus Patients and Caregivers to Shape the Future of Lupus Care
Mar 11, 2025
Sponsored by the National Institute of Minority Health and Health Disparities (NIMHD), Polygon Health Analytics is iSMILE (Individualized Social Risk Management in Systemic Lupus Erythematosus Care)...
Read more
Is Life Science Ready for AI?
Jan 01, 2025
A few days ago, Dr. Geoffrey Hinton, often referred to as the “Godfather of AI,” made a chilling statement: “There is a 10-20 percent probability that...
Read more
Polygon Health Analytics Receives Competitive SBIR Grant from NIMHD to Address Health Disparities in Lupus Care
Nov 19, 2024
Philadelphia, PA — Nov 19, 2024 — Polygon Health Analytics LLC is proud to announce its award of a $295,924 Small Business Innovation Research (SBIR) Phase I...
Read more
Polygon Health Analytics Launches First Cohort of Launchpad Program
Nov 10, 2024
Polygon Health Analytics is excited to announce the successful graduation of the first cohort of its Launchpad Program, a 3-to-6-month train-to-hire initiative designed to prepare emerging...
Read more
Introducing Vaccine Vibes – A Weekly Newsletter for Vaccine R&D
Sep 12, 2024
Staying informed about the latest developments is critical for professionals in the biopharmaceutical industry, especially in the complex world of vaccine research and development (R&...
Read more
Polygon Health Analytics LLC Awarded $400,000 National Cancer Institute Contract
Sep 05, 2024
Philadelphia, PA – September 6, 2024 – Polygon Health Analytics LLC (PHA) is thrilled to announce that it has been awarded a prestigious $399,985 contract by the...
Read more
To My Fellow Data Scientists: Transform a Useful Idea into a Real Business
Jun 23, 2024
I have been building my own startup company for the past 1.5 years. Throughout this journey, I’ve been fortunate to connect with many brilliant...
Read more
Polygon Health Analytics to Present AI-driven chart review capabilities at ISPOR 2024
Apr 25, 2024
Polygon Health Analytics is proud to announce the development of a groundbreaking capability – a Large Language Model (LLM)-facilitated chart review solution. This application of advanced...
Read more
Bridging the Gap: Real-World Data Enhancing Clinical Trials
Mar 12, 2024
Randomized clinical trials (RCTs) have long been recognized as the gold standard for testing the safety and efficacy of pharmaceutical interventions. Despite their rigorous methodology, RCTs...
Read more
View all